Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

The ketogenic diet might improve certain skin conditions, but more research is needed to confirm its effectiveness.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

New imaging tools help doctors better examine hair and scalp health without surgery.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The HCR gene contributes to psoriasis risk.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

Turner's syndrome may be linked to autoimmune diseases like psoriasis and alopecia areata, needing comprehensive care.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Hair transplantation can be safe for well-controlled, stable psoriasis patients with proper care.